AGS-003
– investigational fully personalized cancer immunotherapy designed for treating metastasized renal cell carcinoma (mRCC) or stage IV RCC.
Antigens
– any substance capable of inducing a specific immune response and of reacting with the products of that response
Cancer immunotherapy
– treatment designed to trigger a natural immune response to help the body recognize and kill invading cancer cells (also referred to as cancer vaccines)
Dendritic Cells
– a special type of immune cell that is found in tissues, such as the skin, and boosts immune responses by showing antigens on its surface to other cells of the immune system
Investigational treatment
– a treatment that isn’t yet approved by the U.S. FDA
Leukapheresis
– removal of blood to collect a specific type of blood cell
Metastasis
– when cancer has spread to other organs of the body
Nephrectomy
– surgical removal of a kidney or section of a kidney
Oncologist
– a physician specializing in the diagnosis and treatment of cancer
Renal cell carcinoma
– a type of kidney cancer that starts in the lining of the kidney
Sutent (Sunitinib)
– a common targeted drug therapy for treatment of metastasized kidney cancer
T-Cells
– are a type of white blood cell of great importance to the immune system’s ability to recognize and destroy foreign cells such as bacteria, viruses and cancer cells
Urologist
– a physician who deals with the study and treatment of disorders of the urinary tract in women and the urogenital system in men